rs4148214
Variant names:
Your query was ambiguous. Multiple possible variants found:
Variant summary
Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1
The NM_022437.3(ABCG8):c.561+43T>C variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.584 in 1,601,100 control chromosomes in the GnomAD database, including 277,046 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).
Frequency
Genomes: 𝑓 0.61 ( 28616 hom., cov: 33)
Exomes 𝑓: 0.58 ( 248430 hom. )
Consequence
ABCG8
NM_022437.3 intron
NM_022437.3 intron
Scores
2
Clinical Significance
Conservation
PhyloP100: -0.106
Publications
15 publications found
Genes affected
ABCG8 (HGNC:13887): (ATP binding cassette subfamily G member 8) The protein encoded by this gene is a member of the superfamily of ATP-binding cassette (ABC) transporters. ABC proteins transport various molecules across extra- and intra-cellular membranes. ABC genes are divided into seven distinct subfamilies (ABC1, MDR/TAP, MRP, ALD, OABP, GCN20, White). This protein is a member of the White subfamily. The protein encoded by this gene functions to exclude non-cholesterol sterol entry at the intestinal level, promote excretion of cholesterol and sterols into bile, and to facilitate transport of sterols back into the intestinal lumen. It is expressed in a tissue-specific manner in the liver, intestine, and gallbladder. This gene is tandemly arrayed on chromosome 2, in a head-to-head orientation with family member ABCG5. Mutations in this gene may contribute to sterol accumulation and atherosclerosis, and have been observed in patients with sitosterolemia. [provided by RefSeq, Jul 2008]
ABCG8 Gene-Disease associations (from GenCC):
- sitosterolemiaInheritance: AR Classification: DEFINITIVE, SUPPORTIVE Submitted by: ClinGen, Orphanet, Illumina
- sitosterolemia 1Inheritance: AR Classification: DEFINITIVE, STRONG Submitted by: Labcorp Genetics (formerly Invitae), G2P
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -20 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.87).
BP6
Variant 2-43851865-T-C is Benign according to our data. Variant chr2-43851865-T-C is described in ClinVar as Benign. ClinVar VariationId is 1188927.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.843 is higher than 0.05.
Transcripts
RefSeq
Ensembl
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
|---|---|---|---|---|---|---|---|---|---|---|
| ABCG8 | ENST00000272286.4 | c.561+43T>C | intron_variant | Intron 4 of 12 | 1 | NM_022437.3 | ENSP00000272286.2 | |||
| ABCG8 | ENST00000644611.1 | c.573+43T>C | intron_variant | Intron 4 of 8 | ENSP00000495423.1 |
Frequencies
GnomAD3 genomes AF: 0.609 AC: 92506AN: 151962Hom.: 28581 Cov.: 33 show subpopulations
GnomAD3 genomes
AF:
AC:
92506
AN:
151962
Hom.:
Cov.:
33
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD2 exomes AF: 0.614 AC: 151447AN: 246740 AF XY: 0.616 show subpopulations
GnomAD2 exomes
AF:
AC:
151447
AN:
246740
AF XY:
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.582 AC: 843229AN: 1449020Hom.: 248430 Cov.: 30 AF XY: 0.585 AC XY: 422008AN XY: 721546 show subpopulations
GnomAD4 exome
AF:
AC:
843229
AN:
1449020
Hom.:
Cov.:
30
AF XY:
AC XY:
422008
AN XY:
721546
show subpopulations
African (AFR)
AF:
AC:
22416
AN:
33272
American (AMR)
AF:
AC:
24848
AN:
44700
Ashkenazi Jewish (ASJ)
AF:
AC:
15809
AN:
26080
East Asian (EAS)
AF:
AC:
33111
AN:
39642
South Asian (SAS)
AF:
AC:
60914
AN:
86024
European-Finnish (FIN)
AF:
AC:
30182
AN:
50598
Middle Eastern (MID)
AF:
AC:
3126
AN:
5736
European-Non Finnish (NFE)
AF:
AC:
617435
AN:
1102926
Other (OTH)
AF:
AC:
35388
AN:
60042
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.502
Heterozygous variant carriers
0
19840
39680
59520
79360
99200
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Exome Het
Exome Hom
Variant carriers
0
17414
34828
52242
69656
87070
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome AF: 0.609 AC: 92587AN: 152080Hom.: 28616 Cov.: 33 AF XY: 0.611 AC XY: 45400AN XY: 74314 show subpopulations
GnomAD4 genome
AF:
AC:
92587
AN:
152080
Hom.:
Cov.:
33
AF XY:
AC XY:
45400
AN XY:
74314
show subpopulations
African (AFR)
AF:
AC:
28064
AN:
41476
American (AMR)
AF:
AC:
8362
AN:
15292
Ashkenazi Jewish (ASJ)
AF:
AC:
2098
AN:
3472
East Asian (EAS)
AF:
AC:
4479
AN:
5182
South Asian (SAS)
AF:
AC:
3451
AN:
4820
European-Finnish (FIN)
AF:
AC:
6340
AN:
10564
Middle Eastern (MID)
AF:
AC:
152
AN:
294
European-Non Finnish (NFE)
AF:
AC:
37925
AN:
67958
Other (OTH)
AF:
AC:
1225
AN:
2112
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.506
Heterozygous variant carriers
0
1861
3722
5584
7445
9306
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Genome Het
Genome Hom
Variant carriers
0
780
1560
2340
3120
3900
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
2608
AN:
3478
ClinVar
Significance: Benign
Submissions summary: Benign:3
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Benign:2
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided
- -
Jul 09, 2018
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Sitosterolemia 1 Benign:1
Jul 14, 2021
Genome-Nilou Lab
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
DANN
Benign
PhyloP100
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.